Romesh Subramanian is the founder of Ascidian Therapeutics. Ascidian Therapeutics has raised $50M in total funding. Latest round: Series A. Backed by ATP.
Romesh Subramanian, Ph.D., is the CEO of Ascidian Therapeutics, an RNA-editing biotechnology company. The company emerged from stealth in October 2022 after securing $50 million in Series A funding. He previously served as CEO of Chutes & Ladders Bio.
Full founder directory · Investor directory · Company funding database · Fundraising library